<?xml version='1.0' encoding='utf-8'?>
<document id="30589098"><sentence text="Effect of rifampin on enantioselective disposition and anti-hypertensive effect of benidipine."><entity charOffset="10-18" id="DDI-PubMed.30589098.s1.e0" text="rifampin" /><entity charOffset="83-93" id="DDI-PubMed.30589098.s1.e1" text="benidipine" /><pair ddi="false" e1="DDI-PubMed.30589098.s1.e0" e2="DDI-PubMed.30589098.s1.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s1.e0" e2="DDI-PubMed.30589098.s1.e1" /></sentence><sentence text="In vitro study showed that benidipine is exclusively metabolized by cytochrome P450 (CYP) 3A"><entity charOffset="27-37" id="DDI-PubMed.30589098.s2.e0" text="benidipine" /></sentence><sentence text=" This study evaluated the effect of rifampin on the enantioselective disposition and anti-hypertensive effect of benidipine"><entity charOffset="36-44" id="DDI-PubMed.30589098.s3.e0" text="rifampin" /><entity charOffset="113-123" id="DDI-PubMed.30589098.s3.e1" text="benidipine" /><pair ddi="false" e1="DDI-PubMed.30589098.s3.e0" e2="DDI-PubMed.30589098.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s3.e0" e2="DDI-PubMed.30589098.s3.e1" /></sentence><sentence text="" /><sentence text="Benidipine (8 mg) was administered to healthy subjects with or without repeated rifampin dosing, in a crossover design"><entity charOffset="0-10" id="DDI-PubMed.30589098.s5.e0" text="Benidipine" /><entity charOffset="80-88" id="DDI-PubMed.30589098.s5.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.30589098.s5.e0" e2="DDI-PubMed.30589098.s5.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s5.e0" e2="DDI-PubMed.30589098.s5.e1" /></sentence><sentence text=" Plasma concentrations of (S)-(S)-(+)-α and (R)-(R)-(-)-α isomers of benidipine and blood pressure were measured for up to 24 h after dosing" /><sentence text=" In addition, CYP3A metabolic capacity was evaluated in each subject using oral clearance of midazolam"><entity charOffset="93-102" id="DDI-PubMed.30589098.s7.e0" text="midazolam" /></sentence><sentence text="" /><sentence text="The exposure of (S)-(S)-(+)-α-benidipine was greater than that of (R)-(R)-(-)-α-benidipine by approximately three-fold following single dose of benidipine"><entity charOffset="16-40" id="DDI-PubMed.30589098.s9.e0" text="(S)-(S)-(+)-α-benidipine" /><entity charOffset="66-90" id="DDI-PubMed.30589098.s9.e1" text="(R)-(R)-(-)-α-benidipine" /><entity charOffset="144-154" id="DDI-PubMed.30589098.s9.e2" text="benidipine" /><pair ddi="false" e1="DDI-PubMed.30589098.s9.e0" e2="DDI-PubMed.30589098.s9.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s9.e0" e2="DDI-PubMed.30589098.s9.e1" /><pair ddi="false" e1="DDI-PubMed.30589098.s9.e0" e2="DDI-PubMed.30589098.s9.e2" /><pair ddi="false" e1="DDI-PubMed.30589098.s9.e1" e2="DDI-PubMed.30589098.s9.e1" /><pair ddi="false" e1="DDI-PubMed.30589098.s9.e1" e2="DDI-PubMed.30589098.s9.e2" /></sentence><sentence text=" Repeated doses of rifampin significantly decreased the exposure of both isomers"><entity charOffset="19-27" id="DDI-PubMed.30589098.s10.e0" text="rifampin" /></sentence><sentence text=" Geometric mean ratios (GMRs) (95% CI) of Cmax and AUC∞ for (S)-(S)-(+)-α-benidipine were 0"><entity charOffset="60-84" id="DDI-PubMed.30589098.s11.e0" text="(S)-(S)-(+)-α-benidipine" /></sentence><sentence text="14 (0" /><sentence text="10-0" /><sentence text="18) and 0" /><sentence text="12 (0" /><sentence text="08-0" /><sentence text="18), respectively" /><sentence text=" GMRs (95% CI) of Cmax and AUC∞ for (R)-(R)-(-)-α-benidipine were 0"><entity charOffset="27-31" id="DDI-PubMed.30589098.s18.e0" text="AUC∞" /><entity charOffset="36-60" id="DDI-PubMed.30589098.s18.e1" text="(R)-(R)-(-)-α-benidipine" /><pair ddi="false" e1="DDI-PubMed.30589098.s18.e0" e2="DDI-PubMed.30589098.s18.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s18.e0" e2="DDI-PubMed.30589098.s18.e1" /></sentence><sentence text="10 (0" /><sentence text="06-0" /><sentence text="17) and 0" /><sentence text="10 (0" /><sentence text="06-0" /><sentence text="17), respectively" /><sentence text=" Oral clearances of both isomers were increased equally by approximately 10-fold" /><sentence text=" There were no significant differences in cardiovascular effect following benidipine administration between control and rifampin treatment"><entity charOffset="74-84" id="DDI-PubMed.30589098.s26.e0" text="benidipine" /><entity charOffset="120-128" id="DDI-PubMed.30589098.s26.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.30589098.s26.e0" e2="DDI-PubMed.30589098.s26.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s26.e0" e2="DDI-PubMed.30589098.s26.e1" /></sentence><sentence text=" CYP3A activity using midazolam did not appear to correlate with oral clearance of benidipine"><entity charOffset="22-31" id="DDI-PubMed.30589098.s27.e0" text="midazolam" /><entity charOffset="83-93" id="DDI-PubMed.30589098.s27.e1" text="benidipine" /><pair ddi="false" e1="DDI-PubMed.30589098.s27.e0" e2="DDI-PubMed.30589098.s27.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s27.e0" e2="DDI-PubMed.30589098.s27.e1" /></sentence><sentence text="" /><sentence text="After single administration of racemic benidipine, enantioselective disposition of (S)-(S)-(+)-α- and (R)-(R)-(-)-α-benidipine was observed"><entity charOffset="31-49" id="DDI-PubMed.30589098.s29.e0" text="racemic benidipine" /><entity charOffset="83-126" id="DDI-PubMed.30589098.s29.e1" text="(S)-(S)-(+)-α- and (R)-(R)-(-)-α-benidipine" /><pair ddi="false" e1="DDI-PubMed.30589098.s29.e0" e2="DDI-PubMed.30589098.s29.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s29.e0" e2="DDI-PubMed.30589098.s29.e1" /></sentence><sentence text=" Treatments with rifampin significantly decreased the exposure of both isomers but appeared to marginally affect its blood pressure-lowering effect in healthy subjects"><entity charOffset="17-25" id="DDI-PubMed.30589098.s30.e0" text="rifampin" /></sentence><sentence text=" Impact of coadministration of rifampin on the treatment effects of benidipine should be assessed in hypertensive patients"><entity charOffset="31-39" id="DDI-PubMed.30589098.s31.e0" text="rifampin" /><entity charOffset="68-78" id="DDI-PubMed.30589098.s31.e1" text="benidipine" /><pair ddi="false" e1="DDI-PubMed.30589098.s31.e0" e2="DDI-PubMed.30589098.s31.e0" /><pair ddi="false" e1="DDI-PubMed.30589098.s31.e0" e2="DDI-PubMed.30589098.s31.e1" /></sentence><sentence text="" /></document>